← FDA DRUG APPROVALS

FDA ANDA · ANDA089521

PHENYTOIN SODIUM

Sponsor: HOSPIRA

APPLICATION
ANDA089521
TYPE
ANDA
ORIGINAL APPROVAL
1987-03-17
LATEST ACTION
2014-01-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PHENYTOIN SODIUMDiscontinued
PHENYTOIN SODIUM 50MG/ML · INJECTABLE · INJECTION

Approval history

2014-01-29Labeling · Supplement 11AP
1995-11-30Manufacturing (CMC) · Supplement 3AP
1994-06-06Manufacturing (CMC) · Supplement 2AP
1991-11-12Labeling · Supplement 1AP
1987-03-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →